novo nordisk cuts prices for its glp-1 drugs. WEIGHT-LOSS DRUG ON THE DECLINE! This downward trend isn’t limited to a single medication. As competition increases and more treatment options enter the market, the overall cost of medically Novo cuts GLP-1 prices 70%,

While GLP-1 receptor suppresses glucagon release, the concurrent activation of the glucagon receptor simultaneously increases energy expenditure and enhances weight loss and hepatic fat metabolism

What Is GLP-1 and Why Is It Popular for Weight Loss

Whats more, a recent retrospective, multicenter cohort study denied higher occurrence of nonarteritic anterior ischemic optic neuropathy (NAION) in GLP-1RAs users and suggested that its potential benefits for blood glucose control and cardiovascular health likely outweigh its risks (Chou et al., 2025), despite that a few research have reported association between semaglutide prescription and a higher risk of NAION(61)

There is no need for a formal transfer of records, though knowing your current dose and any side effects you have experienced helps the new provider make informed decisions

Recently, medications known as GLP-1 agonists, including Ozempic, have become increasingly popular due to their ability to support meaningful weight loss, even among individuals without diabetes